Dihydroartemisinin induces autophagy by suppressing NF-κB activation

Area of Science:

• Oncology
• Molecular Biology
• Cellular Biology

Background:

• Nuclear factor-kappa B (NF-κB) and autophagy are key regulators in cancer development.
• The interplay between NF-κB and autophagy in cancer remains incompletely understood.

Purpose of the Study:

• To investigate the effect of dihydroartemisinin (DHA) on autophagy induction in cancer cells.
• To elucidate the role of NF-κB signaling in DHA-mediated autophagy.
• To explore the involvement of reactive oxygen species (ROS) in this pathway.

Main Methods:

• Treatment of various cancer cell lines with dihydroartemisinin (DHA).
• Assessment of autophagy induction.
• Inhibition of NF-κB activity and measurement of ROS levels.

Main Results:

• DHA treatment induced autophagy in multiple cancer cell lines.
• DHA repressed NF-κB activity, leading to autophagy.
• Inhibition of NF-κB increased ROS accumulation, which in turn stimulated autophagy.
• DHA demonstrated a sensitizing effect on certain chemotherapeutics.

Conclusions:

• Dihydroartemisinin (DHA) promotes autophagy in cancer cells via NF-κB repression and ROS generation.
• This mechanism highlights a novel pathway for DHA's anti-cancer effects.
• DHA may enhance the efficacy of existing chemotherapies.